Ananth Bioorganics Limited (formerly Gayatri Bioorganics Limited) held a board meeting on November 5, 2026, which commenced at 6:30 PM and concluded at 8:10 PM at the company's registered office in Hyderabad. The board considered and approved the unaudited financial results for the quarter and half year ended September 30, 2026, along with the limited review report provided by the statutory auditors, MGR & CO Chartered Accountants.

Financial Performance (₹ in Lakhs)

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹353.62
  • Total Income: ₹353.62
  • Total Expenses: ₹348.75
  • Purchase of Stock-In-Trade: ₹326.42
  • Employee Benefits Expenses: ₹2.12
  • Finance Cost: ₹11.35
  • Other Expenses: ₹8.86
  • Profit Before Tax: ₹4.87
  • Net Profit After Tax: ₹4.87
  • Basic and Diluted Earnings Per Share (EPS): ₹0.01

Quarter Ended June 30, 2026 (Q1 FY2026):

  • Revenue from Operations: ₹233.66
  • Total Income: ₹233.66
  • Total Expenses: ₹243.83
  • Loss Before Tax: ₹(10.17)
  • Net Loss After Tax: ₹(10.17)
  • Basic and Diluted Loss Per Share: ₹(0.01)

Half Year Ended September 30, 2026 (H1 FY2026):

  • Revenue from Operations: ₹587.28
  • Total Income: ₹587.28
  • Total Expenses: ₹592.58
  • Loss Before Tax: ₹(5.30)
  • Net Loss After Tax: ₹(5.30)
  • Basic and Diluted Loss Per Share: ₹(0.01)

Comparative Periods:

  • Q2 FY2025 (Sept 30, 2025): Net Loss of ₹(21.13) lakh, EPS of ₹(0.03)
  • H1 FY2025 (Sept 30, 2025): Net Loss of ₹(47.42) lakh, EPS of ₹(0.06)
  • Full Year FY2026 (March 31, 2026): Net Loss of ₹(111.18) lakh, EPS of ₹(0.14)

Capital Structure

  • Paid-up Equity Share Capital remained constant at ₹7,878.81 lakh across all reported periods.
  • Other Equity stood at ₹(11,584.61) lakh as of September 30, 2026, compared to ₹(11,579.31) lakh as of March 31, 2026.
  • Net Worth was negative at ₹(3,705.80) lakh as of September 30, 2026, compared to ₹(3,700.49) lakh as of March 31, 2026.

Balance Sheet Position as at September 30, 2026 (₹ in Lakhs)

  • Total Assets: ₹203.70
  • Trade Receivables: ₹58.63
  • Cash and Cash Equivalents: ₹2.52
  • Other Financial Assets: Not quantified
  • Other Current Assets: ₹142.55
  • Total Liabilities: ₹203.70
  • Non-Current Borrowings: ₹3,754.46
  • Current Borrowings: ₹48.52
  • Trade Payables: Not separately quantified in current period (was ₹16.69 lakh as of March 31, 2026)
  • Other Current Liabilities: ₹106.52

Cash Flow Statement (H1 FY2026, ₹ in Lakhs)

  • Cash Used in Operating Activities: ₹(56.39)
  • Cash Flow from Financing Activities: ₹56.91
  • Proceeds from Borrowings (Net): ₹231.32
  • Increase in Current Borrowings: ₹(174.40)
  • Net Increase in Cash: ₹0.52
  • Cash and Cash Equivalents at End of Period: ₹2.52